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Abstract 
Background: New classes of insecticides with novel modes of action, which can provide effective and prolonged 
control of insecticide-resistant malaria vector populations, are urgently needed for indoor residual spraying. Such 
insecticides can be included in a rotation plan to manage and prevent further development of resistance in mosquito 
vectors of malaria. Chlorfenapyr, a novel pyrrole insecticide with a unique mode of action, is being developed as a 
long-lasting IRS formulation.
Methods: The efficacy of several formulations of chlorfenapyr alone and as mixtures with alpha-cypermethrin were 
evaluated in an experimental hut trial against wild pyrethroid-resistant Anopheles gambiae sensu lato in Cové, Benin, 
in an attempt to identify the most effective and long-lasting formulations for IRS. The trial lasted 12 months. A com-
parison was made with alpha-cypermethrin and bendiocarb formulations. CDC bottle bioassays were performed to 
investigate cross-resistance to chlorfenapyr in the local vector population.
Results: Mortality rates in World Health Organization (WHO) cylinder bioassays were < 5% with pyrethroids due to 
high levels of pyrethroid resistance, but > 95% with bendiocarb thus confirming susceptibility to carbamates in the 
vector population. CDC bottle bioassays showed no cross-resistance between pyrethroids and chlorfenapyr. Overall 
mortality of free-flying mosquitoes entering the experimental huts over the 12-month trial was 4% with alpha-cyper-
methrin and 12% with bendiocarb. The chlorfenapyr solo-formulations induced significantly higher levels of mortality 
(38–46%) compared to the bendiocarb (12% P < 0.001) and to the mixture formulations (18–22%, P < 0.05). The origi-
nal Sylando 240SC formulation of chlorfenapyr was more efficacious than all other novel chlorfenapyr formulations 
tested. Bendiocarb induced > 80% mortality in the first month, but this declined sharply to < 20% by the third month 
while the mortality rates achieved with the chlorfenapyr formulations (38–46%) were persistent lasting 7–10 months. 
The mixtures induced significantly lower percentage mortality than chlorfenapyr-solo formulations. Wall cone bioas-
says only showed mortality rates that were consistent with chlorfenapyr IRS treated huts when the exposure time was 
increased to 2 h.
Conclusion: Indoor residual spraying with chlorfenapyr  (Sylando® 240SC) provides moderate but prolonged 
control of pyrethroid-resistant malaria vectors compared to pyrethroid and bendiocarb IRS. Wall cone bioassays on 
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Background
Indoor residual spraying (IRS) is a key vector control 
intervention for preventing or controlling malaria in 
many malaria-endemic countries [1]. When applied cor-
rectly, IRS can rapidly reduce vector populations and 
interrupt transmission. The use of IRS has increased con-
siderably over the past two decades [2] contributing sig-
nificantly to the remarkable reductions in malaria burden 
observed in endemic countries over this period.
The effectiveness of IRS for vector control depends on 
the residual activity of the insecticide on treated home 
walls and the continued susceptibility of local vectors to 
the insecticides being deployed. Until very recently, this 
intervention relied on a small number of insecticides 
from four classes of chemistry (pyrethroids, organo-
phosphates, carbamates and the organochlorine DDT). 
Most of the insecticides also showed low residual activ-
ity (2–5 months) on wall substrates, thus requiring mul-
tiple rounds of IRS application for effective control [3]. 
Unfortunately, malaria vectors have developed resist-
ance to all four classes of compounds [4, 5]. Resistance to 
pyrethroids and DDT is now widespread and increasing 
in intensity the more they are used, making these com-
pounds less effective as time goes on [5]. This resulted 
in increased use of carbamates and organophosphates in 
recent years [2, 6] driven by the development of a long-
lasting formulation of pirimiphos-methyl  (Actellic® 
300CS) [7]. However, carbamate and organophosphate 
resistance is also increasing in malaria vectors especially 
in West Africa [4, 5, 8, 9].
The development of new IRS insecticides which can 
provide improved and prolonged control of insecticide-
resistant vector populations is critical for maintaining the 
effectiveness of this intervention. Two new IRS insecti-
cide products belonging to the neonicotinoid class have 
very recently been approved by the World Health Organ-
ization (WHO) [10]. As a strategy for managing insecti-
cide resistance in local vector populations, vector control 
programmes are encouraged to implement a rotational 
schedule of IRS insecticides of different modes of action 
to reduce selection pressure on the vector [11]. While 
the newly prequalified IRS insecticides show potential to 
improve the control of insecticide-resistant vector popu-
lations [12–15], an effective rotational strategy which will 
prevent the development of further resistance cannot 
rely on these compounds alone as they contain the same 
active ingredient (clothianidin) and thus share the same 
mode of action; a more diversified portfolio of IRS insec-
ticides is required.
Chlorfenapyr, a pyrrole insecticide has shown poten-
tial to control pyrethroid-resistant Anopheles gambiae. It 
works by targeting the oxidative pathways in the insect’s 
mitochondria disrupting ATP production and thus pre-
senting a novel mode of action for IRS which differs 
from other public health insecticides [16–18]. There are 
currently no records of cross-resistance to chlorfenapyr 
and existing IRS insecticides [18]. While experimental 
hut trials with one formulation of chlorfenapyr for IRS 
 (Sylando® 240SC) have reported comparable mortality 
rates against wild free-flying pyrethroid-resistant malaria 
mosquitoes to some conventional IRS products [17], 
reformulation of insecticides can the increase residual 
activity of many classes of IRS insecticides such as pyre-
throids [19] and organophosphates [7] and improve bio-
availability and efficacy on treated wall substrates.
In this study, the bioefficacy of a series of new formula-
tions of chlorfenapyr and mixtures of chlorfenapyr with 
alpha-cypermethrin for IRS against wild, free-flying pyre-
throid-resistant An. gambiae sensu lato (s.l.) was assessed 
in experimental huts. To provide a more comprehensive 
understanding of the bioefficacy and residual activity of 
chlorfenapyr, the trial was conducted for 12 months and 
comparison was made with IRS with alpha-cypermethrin 
and bendiocarb.
Methods
Study site and experimental huts
The study was performed at the CREC/LSHTM experi-
mental hut site in Cové, southern Benin (7°14′ N 2°18′ 
E). The station is situated at the centre of a large rice-
growing zone which provides extensive mosquito breed-
ing sites throughout the year. The rainy season extends 
from March to October and the dry season from Novem-
ber to February. The trial ran for 12  months from Sep-
tember 2016 to September 2017 in 9 experimental huts 
of the West African design [20]. The huts are built on 
concrete plinths surrounded by water-filled moats to pre-
vent the entry of scavenging ants and are equipped with 
veranda traps to capture exiting mosquitoes. The walls 
are made of brick plastered with cement on the inside, 
with a corrugated steel roof, a ceiling of palm thatch and 
four window slits (1-cm gap) on the walls through which 
chlorfenapyr-treated walls required longer exposure times of 2 h than the customary 30 min indicating that WHO 
guidelines on residual cone bioassays need to be more insecticide-specific.
Keywords: Experimental huts, Chlorfenapyr, Mixtures, Indoor residual spraying, Alpha-cypermethrin, Bendiocarb, 
Sylando, CDC Bottle bioassays, Anopheles, Cové
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mosquitoes enter. The vector species consists of Anoph-
eles coluzzii and An gambiae sensu stricto (s.s.) with the 
latter occurring at lower proportions (~ 23%) mostly in 
the dry season [21]. The vector population is very resist-
ant to pyrethroids but susceptible to carbamates and 
organophosphates. Pyrethroid resistance is mediated by 
L1014 kdr (> 90% frequency) and over-expression of met-
abolic enzymes.
WHO Susceptibility bioassays
To determine the frequency of insecticide resistance in 
the wild vector population during the hut trial, WHO 
cylinder bioassays were performed on 2–5-day old adult 
F1 female mosquitoes emerging from larvae collected 
from breeding sites close the experimental huts. Approx-
imately 100 female mosquitoes per insecticide were 
exposed for 1 h in cohorts of 25 to alpha-cypermethrin 
0.05%, permethrin 0.75%, deltamethrin 0.05% bendiocarb 
0.1% and fenitrothion 1% treated filter papers. Knock-
down was recorded after 1 h and mortality after a 24 h 
holding period.
CDC bottle bioassays to investigate cross‑resistance 
to chlorfenapyr
To investigate cross-resistance to chlorfenapyr and pyre-
throids and determine a discriminating dose for the 
insecticide, CDC bottle bioassays were performed dur-
ing the trial with 2-5  days old pyrethroid-resistant An. 
gambiae s.l. adult F1 female mosquitoes emerging from 
larvae collected from breeding sites close the experi-
mental huts. Approximately 100 female mosquitoes per 
insecticide dose were exposed for 1  h in cohorts of 25 
to bottles treated with chlorfenapyr at 5 different doses 
ranging from 15 to 450 µg/bottle. Mosquitoes were also 
exposed to untreated control and alpha-cypermethrin 
12.5 µg treated bottles. Mosquitoes of the susceptible An. 
gambiae Kisumu strain were also tested for comparison. 
The tests were double-blind; Eppendorf tubes containing 
unknown pre-weighed amounts of the technical grade of 
each dose/insecticide obtained from BASF were used to 
prepare stock solutions and 1 ml of each was applied to 
each bottle.
Experimental hut treatments
Three new formulations of chlorfenapyr coded FS1, FS7, 
and HKI and two new mixture formulations of alpha-
cypermethrin and chlorfenapyr coded FS2 and F5 were 
compared to the reference  Sylando® 240SC, alpha-cyper-
methrin (FS4) and bendiocarb in the experimental hut 
trial at application rates provided in Table  1. The new 
formulations were selected based on their performance 
against susceptible and resistant strains of An. gambiae 
s.l. in preliminary WHO laboratory cone bioassays test-
ing a wider range of formulations on mud and concrete 
substrates. Apart from HKI which was a wettable misci-
ble granule formulation of chlorfenapyr, all other formu-
lations tested in the huts were suspension concentrates 
(Table  1). The formulations were compared to bendio-
carb WP and an untreated hut for the control. 
To prevent contamination from previous trials, hut 
walls were re-plastered and the concrete allowed to 
cure for a month before the trial. The IRS treatments 
were applied using a Hudson Xpert compression sprayer 
equipped with an 8002 flat fan nozzle following WHO 
guidelines [20]. To improve the accuracy of the spray 
application, hut walls were marked with spray swaths and 
a guidance pole attached to the tip of the spray lance to 
enable the spray man to maintain a fixed distance from 
the wall during spraying. Spray men wore full protective 
clothing and huts were sprayed from top to bottom using 
a predetermined lance speed to deliver the target volume. 
The palm thatch used to line the ceiling of the hut was 
sprayed flat on the ground outside the hut and allowed 
to dry before fitting to the ceiling of the hut. The volume 
sprayed was determined by subtracting the volume left in 
the tank after spraying. The actual volume sprayed on the 
Table 1 Experimental hut treatments and insecticide formulations
CFP chlorfenapyr, Alpha alpha-cypermethrin, SC suspension concentrate, WMG wettable miscible granule
SN Insecticide Treatment code Insecticide Formulation Application rate
1 – Control – –
2 Alpha-cypermethrin FS4 Alpha 3.31% SC 30 mg/m2
3 Mixture (CFP + Alpha) FS2 CFP 20.69% + Alpha 3.31% SC 250 mg/m2 + 30 mg/m2
4 Mixture (CFP + Alpha) FS5 CFP 20.69% + Alpha 3.31% SC 250 mg/m2 + 30 mg/m2
5 Chlorfenapyr FS1 CFP 20.69% SC 250 mg/m2
6 Chlorfenapyr FS7 CFP 20.69% SC 250 mg/m2
7 Chlorfenapyr Sylando 240 SC CFP 24% SC 250 mg/m2
8 Chlorfenapyr HKI CFP 24.2% WMG 250 mg/m2
9 Bendiocarb Bendiocarb WP 400 mg/m2
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walls did not deviate significantly from the target applica-
tion rate for each hut (< 15% deviation for any treatment).
Trial procedure and volunteer sleepers
The IRS treatments were applied on 16th September 2016 
and the trial lasted for 12  months. Consenting human 
volunteer ‘sleepers’ slept in the huts from 9:00  p.m. to 
5:00 a.m. each night to attract mosquitoes into the huts. 
To account for individual attractiveness to mosquitoes, 
sleepers were rotated through the huts daily using a sim-
ple Latin square design. At dawn, the volunteer sleepers 
collected dead mosquitoes in the room of the hut and 
all mosquitoes which escaped into the veranda using 
torches and aspirators. Mosquito collections were then 
transferred to the laboratory for processing where they 
were identified according to appropriate identification 
keys and scored for their blood-feeding status and mor-
tality. Delayed mortality was recorded every 24 h for up 
to 72  h. Mosquitoes were held at 25 ± 2  °C during the 
observations.
Outcome measures
The following outcome measures were used to assess the 
efficacy of the treatments in the experimental huts:
1. Deterrence: percentage reduction in the number of 
mosquitoes caught in treated hut relative to the num-
ber caught in the control hut
2. Exiting rates: due to potential irritant effect of treat-
ments expressed as a percentage of the mosquitoes 
collected from the veranda trap
3. Blood feeding rate: percentage of blood-fed mosqui-
toes
4. Inhibition of blood-feeding: reduction in blood-feed-
ing rate relative to the control. This was as follows:
 where Bfu is the proportion of blood-fed mosquitoes 
in the untreated control hut and Bft is the proportion of 
blood-fed mosquitoes in the hut with a specific insecti-
cide treatment.
5. Mortality rate: percentage of dead mosquitoes after a 
72 h holding period.
Assessing spray quality
Before spraying, filter papers (Whatman No 1) measuring 
5 × 5 cm were fixed on each wall in each hut using mask-
ing tape. After spraying, the filter papers were removed, 
carefully packaged in aluminium foil and stored at 4  °C 
100 (Bfu− Bft)/Bfu,
for 10  days after which they were shipped to BASF for 
chemical analysis to assess the quality of the spray appli-
cations using gas chromatography.
Wall cone bioassay exposure time studies
Supplementary bioassays were performed to investigate 
the relationship between exposure time in wall cone bio-
assays and mortality rates of free-flying mosquitoes. Fifty 
laboratory maintained susceptible female An. gambiae 
Kisumu mosquitoes per hut were exposed in cohorts of 
10 for 30  min, 1  h, 2  h and 4  h to walls of huts treated 
with alpha-cypermethrin, Sylando 240SC and the control 
hut using standard WHO cone bioassays. One cone was 
placed on each wall and one on the ceiling. Mortality was 
recorded every 24 h for up to 72 h.
Statistical analysis
Proportional outcomes (blood-feeding, exiting and 
mortality) related to each experimental hut treatment 
were assessed using binomial generalized linear models 
(GLMMs) on Stata (version 2.15.0). A separate model 
was fitted for each outcome. In addition to the fixed 
effect of each treatment, each model included random 
effects to account for the sources of variation between 
the volunteer sleepers and the months of the trial.
Results
WHO resistance bioassays
Over 95% of wild An. gambiae s.l. mosquitoes from 
Cové survived exposure to pyrethroids (deltamethrin, 
permethrin and alpha-cypermethrin) in the WHO 
susceptibility cylinder bioassays thus confirming the 
high levels of pyrethroid resistance in the Cové vec-
tor population (Fig.  1). Mortality with bendiocarb 0.1% 
and fenitrothion 1% treated papers were 95% and 100%, 
respectively demonstrating susceptibility to carbamates 
and organophosphates.
Cross‑resistance CDC bottle bioassays
The mortality rate with alpha-cypermethrin 12.5  µg 
bottles was 48%. Mortality was 100% with all 5 doses of 
chlorfenapyr tested (15 to 450  µg) for both susceptible 
Kisumu and pyrethroid-resistant Cové strains (Fig.  2). 
There was no measurable difference in susceptibility to 
chlorfenapyr between both strains at the doses tested 
indicating no evidence of cross-resistance to chlor-
fenapyr in the wild pyrethroid-resistant vector popula-
tion in Cové.
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Hut trial results
The hut trial results are presented in Table 2 and Figs. 3 
and 4. A total of 32,486 female An. gambiae s.l. were 
collected in the experimental huts during the trial. The 
exiting rates in huts treated with chlorfenapyr formula-
tions (71–80%) were lower than what was observed in 
huts treated with alpha-cypermethrin alone (FS4), the 
mixture formulations (FS2 and FS5) and bendiocarb 
(94–100%, P < 0.05). This can be attributed to the high 
excito-repellent and neurotoxic activities of the pyre-
throid and the carbamate. Blood-feeding rates were 100% 
with the untreated control and 98–100% with all treat-
ments tested. This is expected of the IRS treatments con-
sidering there was no mosquito net barrier to prevent 
feeding, and that mosquitoes feed on sleepers before 
resting on the treated walls.
Overall mortality through the course of the 
12-month trial was 1% in the control hut and 4% in the 
0 20 40 60 80 100
Fenitrothion 1%
Bendiocarb 0.1%
Alpha-cypermethrin 0.05%
Permethrin 0.75%
Deltamethrin 0.05%
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% Mortality (24h) 
Fig. 1 Mortality of wild pyrethroid resistant Anopheles gambiae s.l. from Cové in WHO susceptibility cylinder bioassays. Each bar represents mortality 
of ~ 100 exposed mosquitoes. Error bars represent 95% confidence intervals
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Fig. 2 Mortality of susceptible Anopheles gambiae Kisumu and pyrethroid resistant An. gambiae s.l. Cové in chlorfenapyr treated CDC bottle 
bioassays
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alpha-cypermethrin treated hut (FS4). The chlorfenapyr 
and alpha-cypermethrin mixture formulations induced 
lower levels of overall mortality compared to what was 
achieved with the chlorfenapyr-only formulations (18–
22% vs. 38–46% P < 0.05). Overall mortality was much 
lower with bendiocarb (12%) compared to chlorfenapyr 
alone (38% to 46%, P < 0.05) and mixture formulations 
(18–22%, P < 0.05). The highest mortality was achieved 
with the  Sylando® 240SC formulation and this was sig-
nificantly higher than what was achieved with other chlo-
rfenapyr-only formulations (46% with  Sylando® 240SC 
vs. 38–40% with other chlorfenapyr-only formulations, 
P < 0.05). There was evidence of delayed mosquito mor-
tality with the mixtures and chlorfenapyr formulations 
as mortality increased significantly with these treatments 
when observation time increased from 24 to 72  h; this 
effect was not observed with alpha-cypermethrin alone 
and bendiocarb (Fig. 3).
Monthly mortality of wild mosquitoes in treated 
experimental huts
The monthly mortality rates of wild free-flying pyre-
throid-resistant An. gambiae s.l. entering the IRS treated 
huts in Cové over the 12-month trial are presented in 
Table 2 Results with wild free-flying pyrethroid-resistant An. gambiae s.l. mosquitoes entering IRS treated experimental 
huts in Cové, Benin
*Values along this row bearing the same letter superscript are not significantly different (P > 0.05, logistic regression)
Hut treatments Control Alpha alone Alpha + chlorfenapyr 
mixture formulations
Chlorfenapyr formulations Positive control
Untreated hut FS4 FS2 FS5 FS1 FS7 HKI Sylando® SC Bendiocarb
Females caught 6167 3488 4350 3383 3153 2563 2784 3187 3411
% Deterrence – 43 29 45 49 58 55 48 45
% Exophily 50 100 98 94 80 79 78 71 96
95% conf. limits 48–51 99–100 97–98 93–95 79–81 77–80 77–80 69–72 96–97
N blood-fed 6141 3455 4325 3365 3079 2492 2771 3154 3353
% Blood fed 100 99 99 99 98 97 100 99 98
95% conf. limits 99–100 98–100 99–100 99–100 97–98 96–98 99–100 99–100 97–100
N dead 72 h 50 144 782 746 1243 1028 1044 1462 432
% Overall 72 h mortality* 1a 4b 18c 22d 39e 40e 38e 46f 12g
95% conf. limits 0–2 3–5 17–19 21–23 38–41 38–42 36–39 44–48 11–13
a
b
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e e e
f
g
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Fig. 3 Overall mortality of wild free-flying pyrethroid resistant Anopheles gambiae s.l. Cové in IRS treated experimental huts in Cové, Benin. For 72 h 
mortality, bars bearing the same letter label are not significantly different at the 5% level (P > 0.05, logistic regression). Error bars represent 95% 
confidence intervals. CFP chlorfenapyr
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Fig.  4. Initial mortality with the chlorfenapyr formula-
tions was ~ 44–56% in the first month of the trial. This 
mortality remained more or less steady from month 2 
onwards only dropping to ~ 20–30% after 8–10  months. 
By contrast, mortality with bendiocarb was initially > 80% 
in month 1 but declined very sharply to less than 20% by 
the third month. With the  Sylando® 240SC chlorfenapyr 
formulation, mortality was 40–50% for up to 9  months 
and dropped to 20% after 10 months.
Impact of exposure time in cone bioassays on IRS treated 
walls
Cone bioassay mortality rates of susceptible An. gambiae 
Kisumu mosquitoes exposed to alpha-cypermethrin and 
chlorfenapyr  (Sylando®) treated hut walls for a range 
of exposure times 1  week post-IRS application are pre-
sented in Fig.  5. Mortality with alpha-cypermethrin 
was > 90% independent of exposure time. With chlor-
fenapyr, mortality was very low at the standard 30-min 
exposure time (27%) but increased steadily as exposure 
time was increased to 4  h. A mortality rate of 40–50% 
which was more consistent with the mortality of free-
flying wild mosquitoes in the huts was only achieved 
after 2 h of exposure. Optimal cone bioassay mortality on 
chlorfenapyr treated walls (> 90% mortality) required 4 h 
of exposure.
Assessing spray quality
The results from chemical analysis of filter papers that 
were fixed to hut walls during spraying are presented in 
Table  3. Apart from the FS5 which showed a deviation 
from target dose of 51%, the mean insecticide content 
of the filter papers were generally within the acceptable 
deviation of less than 50% [22] ranging between 160 and 
299 mg/m2 for chlorfenapyr (target was 250 mg/m2) and 
18  mg/m2 to 41  mg/m2 for alpha-cypermethrin alone 
(target was 30 mg/m2).
Discussion
New chemical compounds with novel modes of action 
which can provide both improved and long-lasting resid-
ual control of insecticide-resistant malaria vector popu-
lations are urgently needed for indoor residual spraying 
[1]. The effectiveness and residual activity of IRS often 
depend on the type of formulation of the insecticide 
used. In this study, we evaluated the efficacy of several 
formulations of chlorfenapyr alone and as mixtures with 
alpha-cypermethrin in the controlled household envi-
ronment of an experimental hut study against a naturally 
entering and exiting pyrethroid-resistant vector popula-
tion in an attempt to identify a more effective and longer-
lasting formulation of the insecticide for IRS than the 
reference Sylando 240 SC chlorfenapyr formulation. The 
selection of formulations for testing was based on their 
good performance in preliminary laboratory bioassays of 
a wide range of WG, WP, SC and novel formulations of 
chlorfenapyr on mud and concrete substrates. IRS with 
the carbamate bendiocarb and pyrethroid alpha-cyper-
methrin served as positive controls as these have been 
used in West Africa.
The low overall mortality of free-flying mosquitoes 
in huts treated with alpha-cypermethrin IRS (4%) 
0.0
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Fig. 4 Monthly mortality of wild free-flying pyrethroid resistant Anopheles gambiae s.l. entering IRS treated experimental huts in Cové Benin. Error 
bars represent 95% confidence intervals
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demonstrates the ineffectiveness of pyrethroids for 
IRS in areas with high levels of pyrethroid resistance 
and highlights the need for effective non-pyrethroid 
IRS insecticides. Sylando 240SC formulation of chlor-
fenapyr induced a mean mortality rate over 12 months 
of 46% thus confirming results from previous experi-
mental hut studies [16, 17]. However, contrary to 
expectations, none of the new chlorfenapyr and mix-
ture formulations tested was an improvement over 
Sylando 240SC in the experimental huts thus demon-
strating a major challenge in developing an improved 
more effective formulation of chlorfenapyr based on SC 
or WDP technology for IRS. Throughout the trial, all 
the chlorfenapyr solo and mixture formulations tested 
induced much higher overall mortality compared to 
what was achieved with bendiocarb, a WHO-recom-
mended IRS insecticide to which the vector population 
was fully susceptible, thus showing that chlorfenapyr is 
nonetheless a potentially effective insecticide for IRS.
To ensure that householders in areas with stable 
malaria transmission are protected by IRS, it is desir-
able that the insecticide deployed persists long enough 
on treated home walls to cover the entire transmission 
season, otherwise multiple and resource-demanding IRS 
applications may be required [23]. Initial mortality with 
bendiocarb was 80% but this lasted for only 1 month and 
was almost completely lost by the third month of the trial, 
thus confirming its suitability only for short transmission 
seasons on concrete wall substrates [24]. By contrast, 
the current study demonstrated the long residual activ-
ity of chlorfenapyr (Sylando 240SC) on treated concrete 
walls killing free-flying pyrethroid-resistant malaria vec-
tors substantially for up to 9 months. The mortality rate 
was lower than the initial mortality rate in huts treated 
with bendiocarb but was persistent throughout the study 
and never declined as observed in the bendiocarb treated 
huts. This pattern is unusual and raises the question of 
what level of mortality as demonstrated in an experi-
mental hut is required to provide adequate transmission 
control on a community scale. New classes of chemistry, 
particularly those that have a unique, non-neural mode of 
action are required to undergo cluster randomised trials 
if they are applied for an insecticide-treated net [25], but 
this is not a strict requirement for an IRS. Nevertheless, 
0
20
40
60
80
100
Control Alpha-cypermethrin 30 mg/sqm Chlorfenapyr (Sylando®) 250 mg/sqm
%
 M
or
ta
lit
y 
(7
2h
rs
)
Experimental hut treatments
30mins
1hr
2hrs
4hrs
Fig. 5 Cone bioassay mortality of susceptible Anopheles gambiae Kisumu exposed for a range of exposure times to IRS treated experimental hut 
walls 1 week post-treatment. Error bars represent 95% confidence intervals
Table 3 Chemical analysis of filter papers from IRS-treated 
experimental huts in Cové, Benin
Mean insecticide content
Hut 
treatment
Chlorfenapyr 
content (mg/
m2)
% 
Deviation
Alpha 
content 
(mg/m2)
% Deviation
FS1 299 19 – –
FS2 271 9 41 28
FS4 – – 21 30
FS5 122 − 51 18 40
FS7 242 − 3 – –
Sylando® 164 − 34 – –
HKI 160 − 36 – –
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the question of what level of control in an experimen-
tal hut would translate to transmission control is a valid 
one which requires better evidence. The question of who 
should pay to obtain this evidence also remains open.
While higher levels of mortality of pyrethroid-resist-
ant vector populations have been reported with other 
recently developed novel IRS insecticides in similar trials 
[7, 13–15], effective rotation of IRS insecticides for insec-
ticide resistance management as recommended by the 
GPIRM will require a much larger and more diversified 
portfolio of IRS insecticides [2].
Considering its unique mode of action and long resid-
ual activity against pyrethroid-resistant mosquitoes, 
chlorfenapyr has the potential to efficiently complement 
other IRS compounds in an IRS rotation programme for 
insecticide resistance management. In addition, chlor-
fenapyr IRS has shown potential to complement standard 
pyrethroid only nets in a combined intervention strategy 
against pyrethroid-resistant malaria vectors inducing an 
additive effect of both interventions [16, 26]. It is also 
unknown whether chlorfenapyr, with its unique mode 
of action, has other effects on the vector not apparent in 
experimental huts.
The lower mortality rates achieved with the alpha-
cypermethrin and chlorfenapyr IRS mixture formula-
tions compared to the chlorfenapyr solo IRS formulations 
was consistent with findings from a previous study which 
evaluated a tank mix of alphacypermethrin SC (Fendona 
SC) and chlorfenapyr SC (Sylando SC) formulations 
against the same vector population [17]. This effect in the 
previous study might have been due to the carriers in the 
two formulations masking or covering one another. The 
alternative hypothesis is that high excito-repellent prop-
erty of the pyrethroid may have prevented adequate con-
tact with the more toxic chlorfenapyr component of the 
mixture to allow pick-up of a toxic dose from the treated 
walls. Because this trend with the co-formulated mix-
ture products in the present study was consistent with 
that shown in the earlier tank-mix trial, the neutralising 
effect on chlorfenapyr toxicity was, therefore, more likely 
due to excito-repellency of the pyrethroid in the co-for-
mulated mixtures than on masking by the constituent SC 
carrier formulants. Based on this observation, the manu-
facturing company (BASF) decided to discontinue devel-
opment of the mixture formulation for IRS.
While the percentage mortality of free-flying mos-
quitoes that enter experimental huts and alight on walls 
before or after blood-feeding is the primary measure of 
the efficacy of IRS in WHO phase 2 experimental hut 
trials, the standard WHO technique for measuring and 
monitoring the bioefficacy and residual activity of applied 
IRS is the 30 min cone bioassay on wall surfaces. Previ-
ous studies with chlorfenapyr IRS have demonstrated 
the inadequacy of 30 min exposure to predict the perfor-
mance of chlorfenapyr IRS against free-flying mosquitoes 
[17, 27]. The present study demonstrated that with chlor-
fenapyr, wall cone bioassays may only predict mortality of 
free-flying mosquitoes if the mosquito exposure time is 
increased to 2–4 h. Two-hour exposure may be the aver-
age exposure time free-flying mosquitoes spend on chlo-
rfenapyr IRS surfaces. Chlorfenapyr treated surfaces are 
non-repellent unlike alpha-cypermethrin surfaces [28] 
where 30 min is established as a more appropriate expo-
sure time. This raises the intriguing prospect of insecti-
cide-class specific exposure times. Previous research on 
pirimiphos methyl-treated surfaces indicates a 1 h expo-
sure is the more appropriate and realistic exposure time 
for organophosphate that predicts mortality of free-flying 
mosquitoes [7]. Organophosphates are more repellent 
than chlorfenapyr but less repellent than pyrethroids 
such as alpha-cypermethrin [29]. Insecticide class-spe-
cific exposure time may prove to be an advance on cur-
rent practice and deserves further attention. Research on 
chlorfenapyr is further complicated by its non-neurotoxic 
mode of action on mitochondrial respiratory pathways, 
which is most evident in host-seeking and flying mosqui-
toes. It may be the case that blood-fed mosquitoes resting 
on chlorfenapyr treated walls are less sensitive to the tox-
icity of the insecticide than free-flying, unfed, host seek-
ing mosquitoes approaching an alpha-cypermethrin and 
chlorfenapyr mixture LLIN  (Interceptor® G2) [16]. This 
observation further highlights the need for new testing 
methods and guidelines, which take into consideration 
the mode of action of novel non-neurotoxic insecticides.
Conclusion
Indoor residual spraying with chlorfenapyr provides 
moderate but prolonged control of pyrethroid-resistant 
malaria vectors compared to pyrethroid and bendiocarb 
IRS. The Sylando 240SC formulation of chlorfenapyr 
outperformed all other newly developed formulations 
indicating that the level of mortality achieved was not 
improved by reformulation. New formulations of mix-
tures of chlorfenapyr and alpha-cypermethrin did not 
improve the bioefficacy of the chlorfenapyr IRS alone 
and confirmed the negative effect of alpha-cypermethrin 
in the IRS mixture. Wall cone bioassays on chlorfenapyr 
treated walls required longer exposure times of 2 h than 
the customary 30 min stipulated by the WHO to generate 
data more representative of chlorfenapyr IRS bioefficacy 
in experimental huts. WHO guidelines on residual cone 
bioassays need to be more insecticide-specific.
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